Drug recall · November 2, 2016
Invokamet recall
Why: Labeling: Incorrect or Missing Package Insert - Xarelto prescribing information outserts may be affixed to the exterior of Invokamet bottles in place of the Invokamet prescribing information outsert.
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Invokamet (canagliflozin and metformin HCl) tablets, 150 mg/1,000 mg, 60-count bottle, Rx only, Finished product manufactured by: Janssen Ortho, LLC, Gurabo PR 00778, Manufactured for: Janssen Pharmaceuticals, Inc., Titusville, NJ 08560, NDC 50458-543-60
- Lots / codes
Lot #: 16GG581X, Exp 09/17
- Quantity
- 5346 bottles
- Company
- Janssen Ortho L.L.C., Gurabo, PR
- Distribution
- Nationwide and Puerto Rico
- Initiated
- October 19, 2016 · Voluntary: Firm initiated
- Classified
- October 25, 2016
- Reported
- November 2, 2016
- Ended
- May 14, 2018
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Invokamet
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.